PCSK9 Inhibitors Mechanism of Action and Landmark Trials

What is PCSK9?

Our liver makes a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 regulates how many LDL receptors you have. Studies have shown that if you have naturally high PCSK9, you are more likely to have high cholesterol.

PCSK9 inhibitors decrease LDLR degradation by PCSK9, and thereby improve LDL-C clearance and lower plasma LDL-C

Here are some landmark trials on PCSK9 inhibitors:

Landmark Trials on PCSK9 Inhibitors

1. *FOURIER Trial (2017)*: Evaluated the efficacy and safety of evolocumab (Repatha) in reducing cardiovascular events in patients with established cardiovascular disease. Results showed a 15% reduction in major cardiovascular events.

2. *ODYSSEY OUTCOMES Trial (2018)*: Assessed the efficacy and safety of alirocumab (Praluent) in reducing cardiovascular events in patients with acute coronary syndrome. Results showed a 15% reduction in major cardiovascular events.

3. *SPIRE-1 and SPIRE-2 Trials (2014)*: Evaluated the efficacy and safety of bococizumab (not approved) in reducing LDL-C levels in patients with hypercholesterolemia. Although the trials showed significant LDL-C reductions, the drug was not approved due to immunogenicity concerns.

4. *GAUSS-3 Trial (2014)*: Assessed the efficacy and safety of evolocumab in reducing LDL-C levels in patients with statin intolerance. Results showed significant LDL-C reductions and improved tolerability.

These trials have demonstrated the efficacy and safety of PCSK9 inhibitors in reducing LDL-C levels and cardiovascular events, and have helped establish their role in the management of hypercholesterolemia and cardiovascular disease.

Comments

Approach to Supraventricular Tachycardia - SVT

I would like to share with you about SVTs, or supraventricular tachycardia, today. I'll be focusing on the pathophysiology, ECG features, and the management of SVT today. So this is a brief outline of the lecture today. I will be going through the definition of SVTs, followed by a brief classification of tachyarrhythmias, the pathophysiology behind it all, ECG features, and management principles of SVTs. I will round off the lecture with a clinical scenario related to the topic. This lecture is meant to be a basic introduction to SVTs, and is by all means not exhaustive. So without further ado, let us begin. Supraventricular tachycardias are defined as narrow complex tachycardias where the point of stimulation arises from above the bundle branches. There are many types of SVTs, as will be shown in the next slide, and some are more common than the others. However, in our local context, it is used interchangeably with proximal supraventricular tachycardias, which make up a...

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...

What is Duke treadmill Score (DTS) and How to calculate it?

Watch this simple video on DTS calculation with example case: Commonly asked questions: How to Calculate Duke treadmill Score? What is DTS? How to risk stratify a patient with ETT (Exercise Tolerance Test)? #Cardiology #Non-Invasive risk Stratification

Dr. Usman's Cardiology Notes

Search This Blog